Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Summary 
Presently, Barbara A. Kosacz holds the position of COO, Secretary & General Counsel at Kronos Bio, Inc. Ms. Kosacz is also on the board of 6 other companies.

In the past she held the position of Principal at Cooley LLP and Principal at Cooley Godward LLP (a subsidiary of Cooley LLP), Partner at Cooley LLP and Principal at Cooley Godward LLP (a subsidiary of Cooley LLP), Secretary at Cellerant Therapeutics, Inc., Director at moksha8 Pharmaceuticals, Inc., Secretary at NGM Biopharmaceuticals, Inc., Vice President for iScribe, Inc. and Member of California State Bar Association.

Barbara A. Kosacz received an undergraduate degree from Stanford University and a graduate degree from Berkeley Law University of California.


Current positions of Barbara A. Kosacz 
NameTitle Since
Kronos Bio, Inc.
(Biotechnology & Medical Research)
COO, Secretary & General Counsel 2020
Athira Pharma, Inc.
(Biotechnology & Medical Research)
Independent Director 2021
Phoenix Biotech Acquisition Corp.
(Investment Holding Companies)
Independent Director -
XOMA Corporation
(Biotechnology & Medical Research)
Independent Director 2019
Biotechnology Innovation Organization Director -
Keck Graduate Institute of Applied Life Sciences Trustee -
Arsenal Biosciences, Inc. Director 2021


Holdings of Barbara A. Kosacz 
NameEquities%Valuation
Kronos Bio, Inc. (KRON)
(Biotechnology & Medical Research)
738,0241.30%3,490,854 USD
XOMA Corporation (XOMA)
(Biotechnology & Medical Research)
00.0000%0 USD
Athira Pharma, Inc. (ATHA)
(Biotechnology & Medical Research)
00.0000%0 USD


Barbara A. Kosacz: Personal Network 
Most Read News 
05/11CATHIE WOOD : Tumble in Coinbase pushes Wood's ARK fund closer to pandemic low
RE
05/12MASAYOSHI SON : SoftBank Vision Fund posts $26 billion loss; Son pledges defence
RE
05/14ELON MUSK : Elon Musk says Twitter legal team told him he violated an NDA
RE
05/11ELON MUSK : Musk's delay in disclosing Twitter stake triggers SEC probe - WSJ
RE
05/20XAVIER NIEL : UWR shares spike as billionaire Xavier Niel discloses 27% stake
RE
05/19ELON MUSK : Musk says 'Tesla is on my mind 24/7' amid concerns about Twitter distraction
RE
05/10ELON MUSK : Elon Musk says Tesla open to buying a mining company
RE
05/17ELON MUSK : Prominent hedge funds invested in Twitter before Musk unveiled plans
RE
05/17JPMorgan shareholders vote disapproval of CEO Dimon's special payout
RE
05/06MARTIN SORRELL : Sorrell's S4 sees good 2022 after publishing delayed results
RE
More news


© 2022 People and Ownership :   
Barbara A. Kosacz : Connections